4.6 Article

Melanocortin 4 Receptor-Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis

期刊

AMERICAN JOURNAL OF PATHOLOGY
卷 179, 期 5, 页码 2454-2463

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2011.07.014

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Ministry of Health, Labour and Welfare of Japan, Japan Science and Technology Agency
  3. Takeda Science Foundation
  4. Ono Medical Research Foundation
  5. Naito Foundation
  6. Yamaguchi Endocrine Research Foundation
  7. Medical Research Institute, Tokyo Medical and Dental University
  8. Grants-in-Aid for Scientific Research [21117007, 22390150, 23126508, 22890052] Funding Source: KAKEN

向作者/读者索取更多资源

Obesity may be viewed as a state of chronic low-grade inflammation that participates in the development of the metabolic syndrome. Nonalcoholic steatohepatitis (NASH) is considered a hepatic phenotype of the metabolic syndrome and a high risk for progression to cirrhosis and hepatocellular carcinoma. Although the two hit hypothesis suggests involvement of excessive hepatic lipid accumulation and chronic inflammation, the molecular mechanisms underlying the development of NASH remain unclear, in part because of lack of appropriate animal models. Herein we report that melanocortin 4 receptor deficient mice (MC4R-KO) develop steatohepatitis when fed a high-fat diet, which is associated with obesity, insulin resistance, and dyslipidemia. Histologic analysis reveals inflammatory cell infiltration, hepatocyte ballooning, and pericellular fibrosis in the liver in MC4R-KO mice. Of note, all of the MC4R-KO mice examined developed well-differentiated hepatocellular carcinoma after being fed a high-fat diet for 1 year. They also demonstrated enhanced adipose tissue inflammation, ie, increased macrophage infiltration and fibrotic changes, which may contribute to excessive lipid accumulation and enhanced fibrosis in the liver. Thus, MC4R-KO mice provide a novel mouse model of NASH with which to investigate the sequence of events that make up diet-induced hepatic steatosis, liver fibrosis, and hepatocellular carcinoma and to aid in understanding the pathogenesis of NASH, pursuing specific biomarkers, and evaluating potential therapeutic strategies. (Am J Pathol 2011, 179:2454-2463; DOI: 10.1016/j.ajpath.2011.07.014)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据